MedPath

A study to test the effectiveness of swethakutajadi keram in seborrhoeic dermatitis

Phase 3
Conditions
Health Condition 1: L218- Other seborrheic dermatitis
Registration Number
CTRI/2024/07/071044
Lead Sponsor
Dr Induja V
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Seborrhoeic dermatitis on scalp in the age group 18-70 yrs ,Seborrhoeic dermatitis – 16 point scale = 9 at the baseline visit ,Willing to participate in the study

Exclusion Criteria

Participants in whom oil application over scalp is contraindicated,Taken oral anti-fungal or immunosuppressant agents or any chronic anti-inflammatory or chronic antihistamine drugs within 4 weeks prior to baseline , Used antidandruff anti-psoriatic or anti-seborrhoeic dermatitis shampoos within 2 weeks

prior to baseline.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in score of 16 point scaleTimepoint: baseline,31st day,61th day
Secondary Outcome Measures
NameTimeMethod
standerdisation of the study drug <br/ ><br>scalpdex indexTimepoint: 0th day <br/ ><br>0th day 61st day
© Copyright 2025. All Rights Reserved by MedPath